$26.000
+0.140 (+0.54%)Zum Schluss
PGNY-News
PGNY-Events
Progyny Reports Q2 Revenue of $350.51M
Reports Q2 revenue $350.51M, consensus $348.65M. "The strong second quarter results reflect that member engagement trended to the higher end of our expectations, as members continued to pursue the services they need in order to address their family building and overall health and well-being goals," said Pete Anevski, Chief Executive Officer of Progyny.
Sees Q3 Revenue of $335M-$345M
Sees Q3 revenue $335M-$345M, consensus $350.57M. Sees Q3 adjusted EBITDA $56M-$59M.
Company Raises FY26 Revenue Outlook to $1.36B-$1.39B
Consensus $2.06. Raises FY26 revenue view to $1.36B-$1.39B from $1.37B-$1.41B, consensus $1.38B. Narrows FY26 adjusted EBITDA view to $233M-$240M from $232M-$244M. The company said, "Member engagement typically lessens during the peak of the summer months, and the third quarter guidance reflects a slightly more pronounced seasonal impact on member activity. With our present visibility, activity in September is consistent with the engagement seen over the first half of the year, and this is reflected in the assumptions for the remainder of the year."
Progyny Approves $200 Million Share Repurchase Program
Progyny announced that its Board of Directors has approved a share repurchase program to repurchase up to $200 million of its common stock. The program will be funded through available cash balances.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.